Zusammenfassung
Im Juni 2013 wurden die neuen Leitlinien zur Herzschrittmacher- und Resynchronisationtherapie der European Society of Cardiology (ESC) veröffentlicht. Gegenüber den letzten Leitlinien aus dem Jahr 2007 kam es zu einigen fundamentalen Änderungen. Vor allem wurden die Leitlinien näher am klinischen Bild orientiert. Es wurde besonders Wert auf eine einfache Umsetzbarkeit gelegt. Die neuen Leitlinien richten sich damit nicht nur an Elektrophysiologen, sondern an Kardiologen, Internisten und Allgemeinmediziner.
Abstract
The latest guidelines of the European Society of Cardiology (ESC) on cardiac pacing and cardiac resynchronization therapy were presented and published in June 2013. Compared to the last guidelines from 2007 several substantial changes have been made. The new guidelines are much more clinically oriented with a special focus on practicability. The intention is a better usefulness not only for electrophysiologists but also for cardiologists, internists and general practitioners.
Literatur
Vardas PE, Auricchio A, Blanc JJ et al (2007) Guidelines for cardiac pacing and cardiac resynchronisation therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 28:2256–2295
Brignole M, Auricchio A, Baron-Esquivias G et al (2013) 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 34:2281–2329
Brignole M, Menozzi C, Moya A et al (2012) Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation 125:2566–2571
Nielsen JC, Thomsen PE, Højberg S et al (2011) A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome. Eur Heart J 32:686–696
Cleland JG, Swedberg K, Cohen-Solal A et al (2000) The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of York. Eur J Heart Fail 2:123–132
Bristow MR, Saxon LA, Boehmer J et al (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140–2150
Abraham WT, Fisher WG, Smith AL et al (2002) Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1845–1853
Cleland JG, Daubert JC, Erdmann E et al (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352:1539–1549
Chung ES, Leon AR, Tavazzi L et al (2008) Results of the Predictors of Response to CRT (PROSPECT) Trial. Circulation 117:2608–2616
Linde C, Abraham WT, Gold MR et al (2008) Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 52:1834–1843
Moss AJ, Hall WJ, Cannom DS et al (2009) Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 361:1329–1338
Tang AS, Wells GA, Talajic M et al (2010) Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 363:2385–2395
Curtis AB, Worley SJ, Adamson PB et al (2013) Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl J Med 368:1585–1593
Einhaltung ethischer Richtlinien
Interessenkonflikt. K.-H. Kuck weist auf folgende Beziehungen hin: St. Jude Medical GmbH, Medtronic, Abbott Vascular. T. Tönnis gibt an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kuck, KH., Tönnis, T. Neue europäische Leitlinien für die Herzschrittmacher- und die kardiale Resynchronisationstherapie. Herz 39, 941–951 (2014). https://doi.org/10.1007/s00059-014-4179-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00059-014-4179-x